Invivyd, Inc. ( IVVD) - Key Metrics
IVVD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.04 | -$0.14 | -$0.13 | -$0.14 |
| 2026Q1 | $0.04 | -$0.13 | -$0.13 | -$0.14 |
| 2025Q4 | $0.10 | -$0.06 | -$0.09 | -$0.09 |
| 2025Q3 | $0.08 | -$0.06 | -$0.05 | -$0.05 |
| 2025Q2 | $0.10 | -$0.12 | -$0.11 | -$0.11 |
IVVD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.56 |
| 2026Q1 | 0% | -2.50 |
| 2025Q4 | 0% | -9.60 |
| 2025Q3 | 0% | -4.58 |
| 2025Q2 | 0% | -1.49 |
IVVD
Price: $1
52 week price:
Earnings Per Share: -0.31 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 203.9 million